• Cy5 TSA Fluorescence System Kit for Spatial Biology

  2026-09-25

  Boost fluorescent detection of scarce tissue and cell targets with localized Cy5 deposition, while conserving primary antibody or probe. This practical guide explains how to adapt the kit for IHC, ICC, and FISH—and how to interpret its role alongside emerging spatial proteomics methods.

• Busulfan Workflows for Senescence and Ovarian Injury

  2026-09-24

  Busulfan supports distinct experimental questions: dose-dependent senescence in WI38 fibroblasts and germ-cell injury models. Paired with dual-recombinase lineage tracing, it can help researchers test whether ovarian injury is followed by new oocyte formation—while keeping tissue damage separate from evidence of regeneration.

• nor-Binaltorphimine dihydrochloride in Pain Circuits

  2026-09-24

  nor-Binaltorphimine dihydrochloride offers a pharmacological way to test κ-opioid receptor involvement in pain-circuit hypotheses. This article connects recent mouse evidence on morphine-induced mechanical hypersensitivity with practical assay decisions—and clarifies what receptor antagonism can and cannot establish.

• AZD2461 Workflows for Breast Cancer Research

  2026-09-23

  AZD2461 is a novel PARP inhibitor for probing DNA repair pathway modulation, cell-cycle response, and Pgp-associated resistance in cancer models. Pairing growth and cell-death measurements helps distinguish cytostasis from killing and makes concentration- and time-dependent responses easier to interpret.

• METTL17 Links Mitochondrial Translation to Ferroptosis

  2026-09-23

  The reference study identifies METTL17 as a mitochondrial regulator that supports ferroptosis resistance and tumorigenesis in colorectal cancer by maintaining mitochondrial RNA methylation and translation. Its combination of bioinformatics, cellular loss-of-function experiments, mitochondrial phenotyping, and in vivo models provides a framework for testing ferroptosis vulnerability through mitochondrial gene-expression control.

• Coumestrol in RA-FLS Ferroptosis Research

  2026-09-22

  Coumestrol provides a distinctive way to connect estrogen receptor pharmacology with ferroptosis, mitochondrial stress, and inflammatory signaling in rheumatoid arthritis fibroblast-like synocytes. This practical guide translates the PMAIP1–TRIM3 findings into assay workflows, concentration controls, and troubleshooting strategies for nuclear receptor modulation and endocrine disruption research.

• Dacomitinib (PF-00299804) Research Workflow

  2026-09-22

  Build a rigorous Dacomitinib workflow that connects irreversible ErbB blockade with receptor phosphorylation, cell-cycle control, apoptosis, and mitochondrial stress readouts. The framework also shows how to explore, without overclaiming, whether HER-pathway inhibition modifies ferroptosis biology highlighted in colorectal cancer research.

• Toremifene and the Calcium Signaling Frontier

  2026-09-21

  A translational framework for using Toremifene to connect estrogen receptor biology with the TSPAN18–STIM1 calcium-signaling axis in prostate cancer research, while separating evidence from testable hypotheses.

• Prochlorperazine: D2 Biology to Translation

  2026-09-21

  Prochlorperazine is more than an established antiemetic: it is a mechanistically rich research tool for connecting dopamine D2 receptor antagonism with membrane trafficking, melanoma biology, and translational safety. This article outlines how to build decision-ready assays, interpret cross-domain evidence, and incorporate neuropharmacology risk into oncology and antiviral research strategies.

• Tropisetron Hydrochloride: Assay Guidance

  2026-09-20

  This scenario-based guide explains how Tropisetron Hydrochloride (SKU B2258) can support reproducible receptor, cell-viability, and transporter experiments. It combines product specifications with quantitative 5-HT3, OCT2, and MATE1 evidence to help researchers select controls, solvents, concentrations, and interpretation strategies.

• AG-490: JAK2/STAT6 Assay Strategy

  2026-09-19

  AG-490, also known as Tyrphostin B42, is a multi-kinase probe for dissecting JAK2-, EGFR-, and STAT-linked biology. This article translates recent exosomal SNORD52–JAK2/STAT6 findings into a rigorous assay strategy while defining the controls needed for cancer research and macrophage-polarization studies.

• Metformin Hydrochloride in Whole-Blood Research

  2026-09-18

  Use Metformin Hydrochloride as a tunable metabolic intervention in standardized whole-blood stimulation, linking AMPK biology with cytokine profiling. This workflow complements hepatocyte and disease-model studies while preserving donor-specific immune and plasma context.

• Toremifene Citrate: Breast Cancer Research Workflow

  2026-09-18

  Toremifene Citrate enables controlled interrogation of estrogen receptor signaling, from receptor-proximal binding assays to delayed antiproliferative responses in breast cancer models. This workflow combines concentration-response design, vehicle control, receptor-context validation, and translational interpretation for more reproducible hormone receptor modulation studies.

• Machine Learning Discovery of Senolytics: Study Analysis

  2026-09-17

  The reference study shows that machine-learning models trained only on published screening data can identify senolytic candidates despite limited and heterogeneous datasets. Computational screening followed by human-cell validation identified ginkgetin, periplocin, and oleandrin, offering a cost-efficient framework for early-stage senolytic discovery.

• Exosomal SNORD52 Activates JAK2/STAT6 in HCC

  2026-09-17

  This study identifies hepatoma cell-derived exosomal SNORD52 as a mediator of M2 macrophage polarization in hepatocellular carcinoma through functional engagement of the JAK2/STAT6 pathway. Its exosome-transfer model connects a non-coding RNA cargo with tumor-associated immune remodeling and provides a framework for testing pathway-directed interventions.

7722 records 1/515 page Next 12345 下5页 Last page